Evidence map›Paper›PMID 40015245›Full record

ArticleThe Journal of cell biology2025

TANGO2 is an acyl-CoA binding protein.

Agustin Leonardo Lujan, Ombretta Foresti, Jose Wojnacki, Gonzalo Bigliani, Nathalie Brouwers, Maria Jesus Pena, Stefania Androulaki, Tomomi Hashidate-Yoshida, Maria Kalyukina, Sergey S Novoselov and 2 more

Abstract read
In one paragraph

Article in The Journal of cell biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Oligodendroglial TANGO2 Regulates Lipid Metabolism to Control Motor Coordination.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Mechanisms of heme transport in the mitochondria.Biochemical Society transactions · 2025
    Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Agustin Leonardo LujanCentre for Genomic Regulation (CRG), The Barcelona Institute for Science and Technology , Barcelona, Spain.ORCID 0000-0003-4906-6951
Ombretta ForestiCentre for Genomic Regulation (CRG), The Barcelona Institute for Science and Technology , Barcelona, Spain.ORCID 0000-0002-6878-0395
Jose WojnackiCentre for Genomic Regulation (CRG), The Barcelona Institute for Science and Technology , Barcelona, Spain.ORCID 0000-0002-1659-8698
Gonzalo BiglianiCentre for Genomic Regulation (CRG), The Barcelona Institute for Science and Technology , Barcelona, Spain.ORCID 0000-0001-6909-1308
Nathalie BrouwersCentre for Genomic Regulation (CRG), The Barcelona Institute for Science and Technology , Barcelona, Spain.ORCID 0000-0002-9808-9394
Maria Jesus PenaCentre for Genomic Regulation (CRG), The Barcelona Institute for Science and Technology , Barcelona, Spain.ORCID 0009-0008-2899-5368
Stefania AndroulakiCentre for Genomic Regulation (CRG), The Barcelona Institute for Science and Technology , Barcelona, Spain.ORCID 0000-0002-7541-318X
Tomomi Hashidate-YoshidaDepartment of Lipid Life Science, National Center for Global Health and Medicine (NCGM), Shinjuku-ku, Japan.ORCID 0009-0005-2176-7678
Maria KalyukinaDepartment of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK.ORCID 0000-0001-7907-6662
Sergey S NovoselovDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.ORCID 0000-0002-5491-7522
Hideo ShindouDepartment of Lipid Life Science, National Center for Global Health and Medicine (NCGM), Shinjuku-ku, Japan.ORCID 0000-0002-3443-913X
Vivek MalhotraCentre for Genomic Regulation (CRG), The Barcelona Institute for Science and Technology , Barcelona, Spain.ORCID 0000-0001-6198-7943

Funding

Agencia Estatal de Investigación PID2022-143128NB-I00European Research Council 951146European Union's Horizon Europe 101062382Ministry of Education, Culture, Sports, Science and Technology JP23738333National Center for Global Health and Medicine 22T001Universitat Pompeu Fabra
6 · The paper itself

Abstract

Loss of TANGO2 in humans precipitates metabolic crises during periods of heightened energy demand, such as fasting, infections, or high fever. TANGO2 has been implicated in various functions, including lipid metabolism and heme transport, and its cellular localization remains uncertain. In our study, we demonstrate that TANGO2 localizes to the mitochondrial lumen via a structural region containing LIL residues. Mutations in these LIL residues cause TANGO2 to relocate to the periphery of lipid droplets. We further show that purified TANGO2 binds acyl-coenzyme A, and mutations in the highly conserved NRDE sequence of TANGO2 inhibit this binding. Collectively, our findings suggest that TANGO2 serves as an acyl-coenzyme A binding protein. These insights may provide new avenues for addressing the severe cardiomyopathies and rhabdomyolysis associated with defective TANGO2 in humans.

Indexed as

Acyl Coenzyme ACarrier ProteinsAnimalsHEK293 CellsHumansLipid DropletsMitochondriaMutationProtein BindingAcyl Coenzyme ACarrier Proteins

Identifiers

PMID40015245
PMCPMC11867700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.